Anti-endothelial cell antibodies in systemic sclerosis: Significant association with vascular involvement and alveolo-capillary impairment

Clinical and Experimental Rheumatology

Volumn 16, Issue 5, 1998, Pages 527-532

  Pignone, A ^a   Scaletti, C ^a   Matucci Cerinic, M ^a   Vazquez Abad D ^b   Meroni, P L ^c   Del Papa, N ^c   Falcini, F ^a   Generini, S ^a   Rothfield, N ^b   Cagnoni, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Anti endothelial cell antibodies; Endothelial injury; Systemic sclerosis

Indexed keywords

AUTOANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD VESSEL INJURY; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; CYTOTOXICITY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; FIBROBLAST; HUMAN; LUNG ARTERY PRESSURE; LUNG DIFFUSION; MALE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

AUTOANTIBODIES; BLOOD SEDIMENTATION; CAPILLARIES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUNG DISEASES; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PULMONARY ALVEOLI; SCLERODERMA, SYSTEMIC;

EID: 0031654537     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. PALACIOS-BOIX A, ALARCON-SEGOVIA D: Antibodies to endothelial cells: New clues for the study of vascular damage in the autoimmune diseases. In: CERVERA R, KAMASHTA MA, HUGHES GRV (Eds): Antibodies to Endothelial Cells and Vascular Damage. New York, CRC, 1994: 1-14.
2. CARVALHO D, SAVAGE COS, BLACK CM, PEARSON JD: IgG antiendothelial cell autoantibodies from patients with systemic sclerosis induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium derived cytokines. J Clin Invest 1996; 97: 11-119.
3. DEL PAPA N, GAMBINI D, MERONI PL: Antiendothelial cell antibodies and autoimmune diseases. Clin Rev Allergy 1994; 12: 275-86.
4. CINES DB, LYSS AP, REEBER MJ, BINA M, DEHORATIUS R: Presence of complement fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest 1984; 73: 611-25.
5. BRASILE L, KREMER JM, CLARKE JL, CERILLI J: Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis. Am J Med 1989; 87: 74-80.
6. SAVAGE COS, POTTINGER BE, GASKIN G, LOCKWOOD CM, PUSEY CD, PEARSON JD: Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: Presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 1991; 85: 14-9.
7. DEL PAPA N, MERONI PL, BARCELLINI W et al.: Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin Immunol Immunopathol 1992; 63: 267-74.
8. DEL PAPA N, GUIDALI L, SIRONI M et al.: Antiendothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996; 39: 758-66.
9. DEL PAPA N, GUIDALI L, SALA A et al.: Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-β2-glycoprotein I antibodies react in vitro with endothelial cells through adherent β2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997; 40: 551-61.
10. MATUCCI-CERINIC, KAHALEH BM, LEROY EC: The vascular involvement in systemic sclerosis. In: FURST D (Ed.): Systemic Sclerosis, Baltimore, Williams & Wilkins, 1996: 153-74.
11. SOLLBERG S, MAUCH C, ECKES B, KRIEG T: The fibroblast in systemic sclerosis. Clin Dermatol 1994; 12: 379-86.
12. WHITE B: Immune abnormalities in systemic sclerosis. Clin Dermatol 1994; 12: 349-60.
13. PENNING CA, CUNNINGHAM J, FRENCH MAH. HARRISON G, ROWELL NR, HUGHES P: Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol 1984; 57: 548.
14. MARKS RM, CZERNIECKI M, ANDREWS BS, PENNY R: The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody dependent cellular cytotoxicity. Arthritis Rheum 1988; 31:1524-34.
15. HOLT CM, LINDSEY N, MOULT J et al.: Antibody-dependent cellular cytotoxicity of vascular endothelium: Characterization and pathogenic associations in systemic sclerosis. Clin Exp Immunol 1989; 78: 359-65.
16. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE AMERICAN RHEUMATISM ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
17. LEROY EC, BLACK CM, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
18. VISMARA A, MERONI PL, TINCANI A et al.: Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 1988; 7: 247-53.
19. DEL PAPA N, MERONI PL, TINCANI A et al.: Relationship between anti-phospholipid and anti-endothelial antibodies: Further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol 1992; 10: 37-42.
20. YOUINOU P, MERONI PL, KHAMASHTA MA, SHOENFELD Y: A need for standardization of the anti-endothelial-cell antibody test. Immunol Today 1995; 16: 363-4.
21. DAMIANOVICH M, GILBURD B, GEORGE J et al.: Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J Immunol 1996;156:4946-51.
22. MATUCCI-CERINIC M, PIGNONE A, LOTTI T et al.: Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury? J Rheumatol 1990; 17: 328-30.
23. VAZQUEZ-ABAD D, WALLACE S, SENECAL JL et al.: Anticentromere autoantibodies, evaluation of an ELISA recombinant fusion protein CENP-B as antigen. Arthritis Rheum 1994; 37: 248-52.
24. HILDEBRANDT S, WEINER ES, SENECAL JL, NOELL S, EARNSHAW WC, ROTHFIELD NF: Autoantibodies to topoisomerase I (Scl-70): Analysis by gel diffusion, immunoblot and enzyme-linked immunosorbent assay. Clin Immunol Immunopathol 1990; 57: 399-410.
25. 99mTcDTPA clearance. Resp Med 1989; 83: 403-14.
26. MATUCCI-CERINIC M, PIGNONE A, IANNONE F et al.: Clinical correlation of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: A longitudinal study of plasma ACE level, endothelial injury and lung involvement. Resp Med 1990; 84: 283-7.
27. PIGNONE A, MATUCCI-CERINIC M, LOMBARDI A et al.: High resolution computed tomography in systemic sclerosis. Real diagnostic utilities in the assessment of pulmonary involvement and comparison with other modalities of lung investigation. Clin Rheumatol 1992; 11: 465-72.
28. KAHALEH MB, SULTANY GL, SMITH EA, HUFFSTUTTER JE, LOADHOLT CB, LEROY EC: A modified scleroderma skin scoring method. Clin Exp Rheumatol 1986; 4: 367-9.
29. CARPENTIER PH, FRANCO A, BEANI JC, REYMOND JL, AMBLARD P: Interet de la capillaroscopie periungueale dans le diagnostic precoce de la sclerodermie systemique. Ann Dermatol Venereol 1983; 110: 11-20.
30. ROSEMBAUM J, POTTINGER BE, WOO P et al.: Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988; 72: 450-6.
31. NYLANDER LUNDQUIST E, BACK O, NILSSON TK, RANTAPAA-DAHLQUIST S: Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases. Clin Rheumatol 1992; 11: 248-53.
32. MERONI PL, D'CRUZ D, KHAMASHTA MA, YOUINOU P, HUGHES GRV: Anti-endothelial cell antibodies: Only for scientists or for clinicians too? Clin Exp Immunol 1996; 104: 199-202.
33. D'CRUZ DP, HOUSSIAN FA, RAMIREZ G, et al.: Antibodies to endothelial cells in systemic lupus erythematosus: A potential marker for nephritis and vasculitis. Clin Exp Immunol 1991; 85: 254-61.
34. FRAMPTON G, JAYNE DRW, PERRY GJ, LOCKWOOD CM, CAMERON JS: Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1991; 82: 227-32.
35. BLANN AD, ILLINGWORTH K, JAYSON MIV: Mechanisms of endothelial damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993; 20: 1325-9.
36. NAZIR M, MOOTS RJ, EXLEY A, LUQMAN R. EMERY P, BACON P: Serum angiotensin converting enzyme as an index of activity in vasculitis. Clin Rheumatol 1994: 13: 343-4.
37. VANCHEESWARAN R, MAGOULAS T, EFRAT G: Circulating endothelin 1 levels in systemic sclerosis: A marker of fibrosis or vascular dysfunction? J Rheumatol 1993;33:1197-8.
38. MATUCCI-CERINIC M, JAFFA A, KAHALEH BM: Angiotensin Converting Enzyme: An in vivo and in vitro marker of endothelial injury. J Lab Clin Med 1992; 120: 428-33.
39. HEBBAR M, LASSALLE P, DELMESTE Y et al.: Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjögren's syndrome. Ann Rheum Dis 1007; 56: 230-1.
40. CERVERA R, RAMIREZ G, FERNANDEZ-SOLÀ J et al.: Antibodies to endothelial cells in dermatomyositis: Association with interstitial lung disease. Br Med J 1991; 302: 880-1.
41. SALOJIN KV, LE-TONQUEZE M, SARAUX A et al.: Antiendothelial cell antibodies: Useful markers of systemic sclerosis. Am J Med 1997; 102: 178-85.
42. SAVAGE COS: The interaction of endothelial cells with inflammatory cells in vasculitis. Sarcoidosis 1996; 13: 214-6.
43. KANSE SM, TAKAHASHI K, LAM HC et al.: Cytokines stimulated endothelin release from endothelial cells. Life Sci 1991; 48: 1379-84.